A detailed history of Farther Finance Advisors, LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 71 shares of PRME stock, worth $239. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71
Previous 26 173.08%
Holding current value
$239
Previous $64,000 514.06%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

BUY
$2.73 - $5.56 $122 - $250
45 Added 173.08%
71 $393,000
Q2 2025

Jul 11, 2025

SELL
$1.15 - $2.65 $12,347 - $28,453
-10,737 Reduced 99.76%
26 $64,000
Q1 2025

Apr 14, 2025

BUY
$1.72 - $3.35 $18,467 - $35,968
10,737 Added 41296.15%
10,763 $19.2 Million
Q1 2024

May 13, 2024

BUY
$6.35 - $9.39 $165 - $244
26 New
26 $176,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $323M
More about PRME
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.